Medical Technology Industry in
Rotkreuz

Roche Diagnostics (Schweiz) AG

Since 1978 · 101–500 empl.·4.5(44)

The core activity of Roche Diagnostics (Switzerland) AG is the development, distribution and provision of innovative products and services for the prevention, diagnosis and monitoring of diseases, particularly in the field of in-vitro diagnostics. This includes, among other things, the manufacture and distribution of diagnostic products, such as laboratory equipment, test kits and software solutions, as well as the provision of services such as support, consulting and training for medical professionals and laboratories.

Renggli AG

Since 1970 · 11–20 empl.·4.7(20)

Renggli AG is a provider of laboratory and apparatus construction services. The core activities include planning, production, installation, instruction and maintenance of laboratory and apparatus construction solutions, including consulting and supporting customers on technical issues. The company also offers service and qualification services to ensure the functionality of its products.

Coloplast AG

Since 1995 · 21–50 empl.·3.7(6)

The core activity of Coloplast is the development and provision of medical products and services for people with personal and intimate impairments, particularly in the areas of ostomy care, continence care, wound care and urology.

Novapura AG

Since 2006 · 1–10 empl.·5.0(2)

The core activity of Novapura AG is the development and manufacture of systems for biological decontamination and disinfection, particularly products and solutions for combating germs, bacteria and other microorganisms. This includes, among other things, disinfectants, antimicrobial coatings and additives, disinfection robots, as well as analysis methods for air germ measurement and data logging.

Sciensus AG

Since 2004 · 21–50 empl.

Sciensus is a healthcare service provider specializing in the care of patients with rare diseases. The company's core activities include: Procurement, storage, and distribution of pharmaceuticals (Sciensus Wholesale AG); Dispensing of pharmaceuticals and medical devices to patients (Sciensus Apotheke AG); Coordination of patient care with medications and infusion equipment (Sciensus AG); Development and implementation of business development strategies to explore new business areas and partnerships; and Support for patients in administrative matters and provision of patient support programs. Overall, Sciensus offers a specialized value chain for the care of patients with rare diseases, from procurement and storage of pharmaceuticals to personalized patient care in their homes.

Globus Medical GmbH

Since 2008 · 101–500 empl.

The core activity of Globus Medical is the development, manufacture and marketing of medical products and technologies for orthopedics and neurosurgery, particularly in the areas of knee and hip reconstruction, regenerative biologics and enabling technologies. The company focuses on developing innovative solutions for the surgical treatment of patients and offers a comprehensive portfolio of products and services, including training, research and clinical support.

Diasorin Switzerland AG

Since 2013 · 21–50 empl.

The company is active in the field of medical diagnostics, particularly in the areas of immunodiagnostics and molecular diagnostics. It develops and distributes innovative products and solutions for healthcare, including diagnostic tests and systems that help doctors obtain fast, precise and reliable results about their patients' health status.

NeuroGyn AG

Since 2014 · 1–10 empl.

NeuroGyn AG is a medtech company that develops and markets neurotechnology solutions for pelvic nerve disorders. The company supplies stimulation systems and surgical applicators (e.g. the Courve Tunneling Applicator) and a dedicated pelvic neurostimulator (PosStim), and supports procedures such as the LION and GNS therapies for bladder, bowel, pain, sexual and mobility disorders.

Deep Breath Intelligence AG

Since 2018 · 11–20 empl.

The core activity of Deep Breath Intelligence AG (DBI) is the development and application of breath analysis technologies for the healthcare and pharmaceutical industries. DBI offers clinical trial services, analyzing breath samples to gain insights into various diseases such as epilepsy, respiratory diseases, Long Covid, lung cancer, and metabolic disorders. The company also develops products like the DBI-EPIbreath system, used for breath analysis and disease detection. DBI collaborates closely with pharma and healthtech companies to advance precision medicine through innovative breath analysis technologies.

Cimed AG

Since 2003 · 1–10 empl.

Polpharma Biologics International AG

Since 2025 · 1–10 empl.

Polpharma Biologics International AG develops and commercialises biosimilars and supports them from early development through clinical development, regulatory affairs and quality to commercial supply. The company focuses on biologic medicines and partner programs across the product lifecycle.

Align Technology Switzerland GmbH

Since 2019 · 101–500 empl.·2.6(11)

The core activity of Align Technology Switzerland GmbH is the development, manufacture and marketing of transparent aligner therapies, in particular the Invisalign system, for the correction of tooth misalignments and to support dentists and orthodontists in the treatment of their patients.